JP2022174207A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2022174207A5 JP2022174207A5 JP2022143550A JP2022143550A JP2022174207A5 JP 2022174207 A5 JP2022174207 A5 JP 2022174207A5 JP 2022143550 A JP2022143550 A JP 2022143550A JP 2022143550 A JP2022143550 A JP 2022143550A JP 2022174207 A5 JP2022174207 A5 JP 2022174207A5
- Authority
- JP
- Japan
- Prior art keywords
- gene
- stat1
- ch25h
- disease
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762506782P | 2017-05-16 | 2017-05-16 | |
| US62/506,782 | 2017-05-16 | ||
| JP2019563786A JP7675502B2 (ja) | 2017-05-16 | 2018-05-09 | アルツハイマー病の治療用組成物および治療方法 |
| PCT/US2018/031901 WO2018213081A1 (en) | 2017-05-16 | 2018-05-09 | Compositions and methods for treating alzheimer's disease |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019563786A Division JP7675502B2 (ja) | 2017-05-16 | 2018-05-09 | アルツハイマー病の治療用組成物および治療方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022174207A JP2022174207A (ja) | 2022-11-22 |
| JP2022174207A5 true JP2022174207A5 (https=) | 2023-03-27 |
Family
ID=64274628
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019563786A Active JP7675502B2 (ja) | 2017-05-16 | 2018-05-09 | アルツハイマー病の治療用組成物および治療方法 |
| JP2022143550A Pending JP2022174207A (ja) | 2017-05-16 | 2022-09-09 | アルツハイマー病の治療用組成物および治療方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019563786A Active JP7675502B2 (ja) | 2017-05-16 | 2018-05-09 | アルツハイマー病の治療用組成物および治療方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US11873321B2 (https=) |
| EP (1) | EP3628008A4 (https=) |
| JP (2) | JP7675502B2 (https=) |
| KR (1) | KR20200010311A (https=) |
| CN (2) | CN111132694B (https=) |
| AU (1) | AU2018270906B2 (https=) |
| CA (1) | CA3063217A1 (https=) |
| TW (1) | TW201900216A (https=) |
| WO (1) | WO2018213081A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20200010311A (ko) * | 2017-05-16 | 2020-01-30 | 제네로스 바이오파마 리미티드 | 알츠하이머병의 치료를 위한 조성물 및 방법 |
| CN111500694B (zh) * | 2019-01-31 | 2023-02-24 | 中国科学院脑科学与智能技术卓越创新中心 | Baz2b基因作为靶点在缓解衰老中的应用 |
| JP2023521646A (ja) * | 2020-03-31 | 2023-05-25 | ウィルフレッド ジェフリーズ | アルツハイマー病の治療方法 |
| CA3259413A1 (en) * | 2022-06-13 | 2023-12-21 | The University Of Queensland | USES OF JAK INHIBITORS IN THE MANAGEMENT OF DEPRESSION AND CENTRAL NERVOUS SYSTEM (CNS) DISEASES ASSOCIATED WITH INFLAMMATION |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7285526B2 (en) * | 1995-07-14 | 2007-10-23 | Meiogen Biotechnology Corporation | Interferon antagonists useful for the treatment of interferon related diseases |
| US20020188012A1 (en) * | 1998-01-28 | 2002-12-12 | Bisgaier Charles Larry | Method for treating Alzheimer's disease |
| US20060275294A1 (en) | 2002-08-22 | 2006-12-07 | Omoigui Osemwota S | Method of prevention and treatment of aging, age-related disorders and/or age-related manifestations including atherosclerosis, peripheral vascular disease, coronary artery disease, osteoporosis, arthritis, type 2 diabetes, dementia, alzheimers disease and cancer |
| US8771700B2 (en) * | 2006-08-23 | 2014-07-08 | Rutgers, The State University Of New Jersey | Interferon antagonists, antibodies thereto and associated methods of use |
| US9272029B2 (en) * | 2009-03-26 | 2016-03-01 | Ibc Pharmaceuticals, Inc. | Interferon lambada-antibody complexes |
| US9987224B2 (en) * | 2011-02-04 | 2018-06-05 | Joseph E. Kovarik | Method and system for preventing migraine headaches, cluster headaches and dizziness |
| EP3140403A4 (en) * | 2014-05-09 | 2017-12-20 | Université Laval | Prevention and treatment of alzheimer's disease by genome editing using the crispr/cas system |
| ES2731437T3 (es) * | 2014-11-21 | 2019-11-15 | Regeneron Pharma | Métodos y composiciones para la modificación genética dirigida mediante el uso de pares de ARN guías |
| KR20200010311A (ko) * | 2017-05-16 | 2020-01-30 | 제네로스 바이오파마 리미티드 | 알츠하이머병의 치료를 위한 조성물 및 방법 |
-
2018
- 2018-05-09 KR KR1020197036561A patent/KR20200010311A/ko not_active Ceased
- 2018-05-09 AU AU2018270906A patent/AU2018270906B2/en active Active
- 2018-05-09 WO PCT/US2018/031901 patent/WO2018213081A1/en not_active Ceased
- 2018-05-09 JP JP2019563786A patent/JP7675502B2/ja active Active
- 2018-05-09 CN CN201880045403.4A patent/CN111132694B/zh active Active
- 2018-05-09 US US16/613,264 patent/US11873321B2/en active Active
- 2018-05-09 CA CA3063217A patent/CA3063217A1/en active Pending
- 2018-05-09 EP EP18802949.0A patent/EP3628008A4/en active Pending
- 2018-05-09 CN CN202411664773.XA patent/CN119488598A/zh active Pending
- 2018-05-16 TW TW107116606A patent/TW201900216A/zh unknown
-
2022
- 2022-09-09 JP JP2022143550A patent/JP2022174207A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022174207A5 (https=) | ||
| JP2022191257A5 (https=) | ||
| JP2022095882A5 (ja) | 医薬組成物 | |
| JP2024088668A5 (https=) | ||
| JP2005526107A5 (https=) | ||
| JP2021534129A5 (https=) | ||
| CA2530006A1 (en) | Phenylcarboxylate beta-secretase inhibitors for the treatment of alzheimer's disease | |
| JP2023076465A5 (https=) | ||
| JP2006506425A5 (https=) | ||
| DE60107820D1 (de) | Neue verwendung von phenylheteroalkylamin-derivaten | |
| JP2005509662A5 (https=) | ||
| JP2013528655A5 (https=) | ||
| TNSN05163A1 (fr) | Derives de pyrrolo-pyrazole substitues servant d'inhibiteurs de kinases | |
| CN115315423A (zh) | 取代芳基类化合物 | |
| JP2021528488A5 (https=) | ||
| Aufdemorte et al. | Griseofulvin in the treatment of three cases of oral erosive lichen planus | |
| JPH05163139A (ja) | 抗動脈硬化剤 | |
| MA46268B1 (fr) | Dérivés de 5-[2-(pyridin-2-ylamino)-1 ,3-thiazol-5-yl]-2,3-dihydro-1h-isoindol-1-one et leur utilisation en tant qu'inhibiteurs doubles de phosphatidylinositol 3-kinase delta & gamma | |
| CA2526989A1 (en) | Hydroxyamidine and hydroxyguanidine compounds as urokinase inhibitors | |
| JP2017132781A5 (https=) | ||
| JP2021512921A5 (https=) | ||
| JP2023022236A5 (https=) | ||
| JP2006510606A5 (https=) | ||
| JP2004502684A5 (https=) | ||
| JP2010500284A5 (https=) |